Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthopediatrics (KIDS) Revenue (2016 - 2026)

Orthopediatrics has reported Revenue over the past 11 years, most recently at $59.4 million for Q1 2026.

  • For Q1 2026, Revenue rose 13.26% year-over-year to $59.4 million; the TTM value through Mar 2026 reached $243.3 million, up 14.52%, while the annual FY2025 figure was $236.3 million, 15.45% up from the prior year.
  • Revenue for Q1 2026 was $59.4 million at Orthopediatrics, down from $61.6 million in the prior quarter.
  • Over five years, Revenue peaked at $61.6 million in Q4 2025 and troughed at $23.4 million in Q1 2022.
  • A 5-year average of $45.4 million and a median of $44.7 million in 2024 define the central range for Revenue.
  • Biggest five-year swings in Revenue: rose 9.11% in 2022 and later skyrocketed 41.46% in 2024.
  • Year by year, Revenue stood at $31.0 million in 2022, then grew by 21.36% to $37.6 million in 2023, then surged by 40.02% to $52.7 million in 2024, then rose by 16.97% to $61.6 million in 2025, then dropped by 3.64% to $59.4 million in 2026.
  • Business Quant data shows Revenue for KIDS at $59.4 million in Q1 2026, $61.6 million in Q4 2025, and $61.2 million in Q3 2025.